The Department of Oncology‑Pathology at Karolinska Institutet has announced the recipients of the 2026 Blue Sky Grant, an internal funding call aimed at supporting innovative, cross‑disciplinary research led by early‑career researchers.
The grant supports projects carried out by pairs of postdoctoral researchers and/or PhD students from different research groups at the department. Each selected project has been awarded SEK 300,000 to be used during 2026, enabling exploratory research and new scientific collaborations.
The grant attracted strong interest and highlights the scope and creativity of early‑career research at the Department of Oncology‑Pathology.
We warmly congratulate the recipients of the 2026 Blue Sky Grant:
- Alberto Molina and Adrián García-Moreno
An orthogonal multi-omics approach to demonstrate stress-induced pseudogene translation as a source for cancer neoantigens
- Amos Tuval and Domenico Scaramozzino
Uncovering the dynamic structure of pseudo‑mutant p53 in acute myeloid leukaemia
- James Haslam and Haris Babacic
Investigating the global effects of SMUG1 loss on translation for treatment optimisation
- Karin Wallander and Christian Sommerauer
Decoding genetic chaos in soft‑tissue sarcomas with scalable multi‑modal single‑cell genomics
- Konstantinos Georgiadis and Cheng‑De Liu
Longitudinal profiling of plasma extrachromosomal circular DNA in endocrine receptor‑positive breast cancer to inform biomarker discovery
- Lipeng Ren and Jiacheng Zhu
Decoding high‑grade transformation through integrated spatial and single‑cell transcriptomics of synchronous differentiated and anaplastic thyroid carcinomas
- Mireia Cruz de los Santos and Albano Cáceres Verschae
Therapy‑induced ICAM1‑enriched extracellular vesicles as immune escape drivers in sarcoma patients
- Rong Deng and Owen Hovey
From tumour to cell type: protein‑level dissection of immunotherapy response in early‑stage triple‑negative breast cancer
